Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: May 26, 2022

CLINICAL TRIALS PROFILE FOR SOMAVERT

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Somavert

Subscribe to access the full database, or Sign up for a Free Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00151437 ↗	Canadian Pegvisomant Compassionate Study In Acromegalic Patients	Completed	Pfizer	Phase 4	2004-11-01	The purposes of this study are: 1) to provide SOMAVERT for compassionate use to patients with acromegaly or who have completed clinical trials and were responsive, and 2) to evaluate the safety and tolerability of SOMAVERT.
NCT00476879 ↗	Growth Hormone During Fasting.Signaltransduktion in Muscle and Adipose Tissue and Changes in Intrahepatic Lipid Content	Completed	Aarhus University Hospital	N/A	2006-08-01	The purpose of this study is to examine the effects of growth hormone during fasting in healthy lean men.
NCT00476879 ↗	Growth Hormone During Fasting.Signaltransduktion in Muscle and Adipose Tissue and Changes in Intrahepatic Lipid Content	Completed	Pfizer	N/A	2006-08-01	The purpose of this study is to examine the effects of growth hormone during fasting in healthy lean men.
NCT00476879 ↗	Growth Hormone During Fasting.Signaltransduktion in Muscle and Adipose Tissue and Changes in Intrahepatic Lipid Content	Completed	University of Aarhus	N/A	2006-08-01	The purpose of this study is to examine the effects of growth hormone during fasting in healthy lean men.
NCT00552851 ↗	Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant	Unknown status	Pfizer	Phase 4	2006-06-01	The purpose of this study is to evaluate changes in left ventricular mass and cardiac function in patients with active acromegaly before and after treatment with the growth hormone receptor antagonist pegvisomant for one year.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Somavert

Condition Name

Chart
Table

Condition Name for Somavert
Intervention	Trials
Acromegaly	9
Insulin Resistance	2
Impaired Glucose Tolerance	1
Lung Neoplasms	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Somavert
Intervention	Trials
Acromegaly	9
Insulin Resistance	2
Obesity	1
Metabolic Diseases	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Somavert

Trials by Country

Map
Table

Trials by Country for Somavert
Location	Trials
Canada	8
United States	6
Denmark	3
Germany	2
Finland	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Somavert
Location	Trials
California	3
Oregon	1
Tennessee	1
Minnesota	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Somavert

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Somavert
Clinical Trial Phase	Trials
Phase 4	5
Phase 3	1
Phase 2	1
[disabled in preview]	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Somavert
Clinical Trial Phase	Trials
Completed	9
Unknown status	3
Active, not recruiting	1
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Somavert

Sponsor Name

Chart
Table

Sponsor Name for Somavert
Sponsor	Trials
Pfizer	5
Aarhus University Hospital	3
University of Aarhus	3
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Somavert
Sponsor	Trials
Other	19
Industry	7
NIH	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon

Express Scripts

Merck

Mallinckrodt

Baxter

McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.